{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:35:13Z","timestamp":1767180913992,"version":"build-2238731810"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055589","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T16:54:27Z","timestamp":1364316867000},"page":"e55589","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)"],"prefix":"10.1371","volume":"8","author":[{"given":"Gabriella","family":"Masszi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter Maria","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Tarszabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Benko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Buday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Tokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyorgy L.","family":"Nadasy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Beny\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"Varbiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"American Association of Clinical Endocrinologists (2005) Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome Endocrine Practice Vol.11 No.2.","DOI":"10.4158\/EP.11.2.125"},{"issue":"95(5)","key":"ref2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"Metab","author":"RA Wild","year":"2010","journal-title":"J Clin Endocrinol"},{"issue":"88(6)","key":"ref3","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"Metab","author":"RC Christian","year":"2003","journal-title":"J Clin Endocrinol"},{"key":"ref4","first-page":"661","article-title":"Internal carotid artery haemodynamics in women with polycystic ovaries. Clin. Sci. (Lond)","volume":"98","author":"K Lakhani","year":"2000"},{"key":"ref5","first-page":"5088","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab","volume":"90","author":"M Kravariti","year":"2005"},{"issue":"17(4)","key":"ref6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"Update","author":"PC de Groot","year":"2011","journal-title":"Hum Reprod"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"ME Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"ref8","first-page":"171","article-title":"Direct effects of estrogen on the vessel wall. Med Res Rev","volume":"21","author":"A Cignarella","year":"2001"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ctcp.2012.01.005","article-title":"Therapeutic effects of calcium & vitamin D supplementation in women with PCOS","volume":"18(2)","author":"R Firouzabadi","year":"2012","journal-title":"Complement Ther Clin Pract May"},{"key":"ref10","first-page":"195","article-title":"Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res","volume":"32(3)","author":"HR Ardabili","year":"2012","journal-title":"Mar"},{"key":"ref11","first-page":"209","article-title":"Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr. Vasc","volume":"3","author":"L Vir\u00e1g","year":"2005","journal-title":"Pharmacol"},{"key":"ref12","first-page":"235","article-title":"Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev","volume":"25","author":"P Pacher","year":"2007"},{"key":"ref13","first-page":"2","article-title":"Role of the peroxynitrite-poly(ADP ribose) polimerase pathway in human disease. Am J Pathol","volume":"173","author":"P Pacher","year":"2008"},{"key":"ref14","first-page":"4","article-title":"Activation of poly(ADP-ribose) polymerase by myocardial ischaemia and coronary reperfusion in human circulating leukocytes","volume":"221\u2013228","author":"E T\u00f3th-Zs\u00e1mboki","year":"2006","journal-title":"Mol Med 12"},{"issue":"123","key":"ref15","first-page":"366","article-title":"Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell. Liao Int. J","volume":"Cardiol","author":"L Yao","year":"2008"},{"issue":"12","key":"ref16","first-page":"143","article-title":"Activation of the poly(ADP-ribose) polymerase pathway in human heart failure","volume":"Med","author":"A Moln\u00e1r","year":"2006","journal-title":"Mol"},{"key":"ref17","first-page":"684","article-title":"Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase. Circ Res","volume":"89","author":"FG Soriano","year":"2001"},{"key":"ref18","first-page":"626","article-title":"Novel modulators of poly(ADP-ribose)polymerase. Trends Pharmacol Sci","volume":"27","author":"C Szabo","year":"2006"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.0803565","article-title":"Poly(ADP-Ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death an modulating inflammation","volume":"182(11)","author":"NR Jog","year":"2009","journal-title":"J Immunol, Jun 1"},{"key":"ref20","first-page":"359","article-title":"A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial. J Thromb Thrombolysis","volume":"27(4)","author":"DA Morrow","year":"2009"},{"key":"ref21","first-page":"947","article-title":"Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. Int J Mol Med","volume":"19","author":"JG Mabley","year":"2007"},{"key":"ref22","first-page":"812","article-title":"Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J. Pharmacol. Exp. Ther","volume":"315(2)","author":"JG Mabley","year":"2005"},{"issue":"25","key":"ref23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.jcbfm.9600059","article-title":"Ischemic nitric oxide and poly(ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection","volume":"Metab","author":"LD McCullough","year":"2005","journal-title":"J Cereb Blood Flow"},{"key":"ref24","first-page":"210","article-title":"Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol","volume":"217(1)","author":"M Yuan","year":"2009"},{"key":"ref25","first-page":"3781","article-title":"A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome. Endocrinology","volume":"148","author":"L Manneras","year":"2007"},{"key":"ref26","first-page":"641","article-title":"Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis","volume":"20","author":"R Przybylski","year":"2010"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"H386","DOI":"10.1152\/ajpheart.01042.2009","article-title":"Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(\u2212\/\u2212) mice","volume":"299","author":"A Buday","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref28","first-page":"952","article-title":"Rapid \u2018glycaemic swings\u2019 induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia","volume":"52","author":"EM Horv\u00e1th","year":"2009"},{"key":"ref29","first-page":"267","article-title":"Quantification of PARP activity in human tissues: ex vivo assays in blood cells and immunohistochemistry in human biopsies. Methods Mol Biol","volume":"780","author":"EM Horvath","year":"2011"},{"key":"ref30","first-page":"233","article-title":"Gender. sex hormones and vascular tone. Am J Physiol Regul Integr Comp Physiol","volume":"286","author":"JM Orshal","year":"2004"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Miller VM (2010) Sex-based differencies in vascular function. Women's Health. 6; 737\u2013752.","DOI":"10.2217\/whe.10.53"},{"key":"ref32","first-page":"159","article-title":"Effect of acute and long-term treatment with 17-beta-estradiol on the vasomotor responses in rat aorta. Br J Pharmacol","volume":"126","author":"HL Andersen","year":"1999"},{"key":"ref33","first-page":"1301","article-title":"Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolits. Am J Physiol Heart Circ Physiol","volume":"298","author":"M Perusquia","year":"2010"},{"key":"ref34","first-page":"2170","article-title":"Modulation of aortic vascular reactivity by sex hormones in a male rat model of metabolic syndrome. Life Sci","volume":"80","author":"IP Torres","year":"2007"},{"key":"ref35","first-page":"253","article-title":"Long-term oestrogen treatment does not alter systemic arterial compliance and haemodynamics in biological males. Coron Artery Dis","volume":"11","author":"G New","year":"2000"},{"key":"ref36","first-page":"H2444","article-title":"Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol","volume":"294","author":"M Li","year":"2008"},{"key":"ref37","first-page":"254","article-title":"Dihydrotestosterone protects human vascular endothelial cells from H2O2-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK. European Journal of Pharmacology","volume":"643","author":"Z Xu","year":"2010"},{"key":"ref38","first-page":"375","article-title":"The therapeutic potential of poly(ADP-ribose)polymerase inhibitors. Pharmacol Rev","volume":"54","author":"L Virag","year":"2002"},{"key":"ref39","first-page":"1827","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab","volume":"96","author":"J Puurunen","year":"2011"},{"key":"ref40","first-page":"751","article-title":"Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci","volume":"62","author":"K Erd\u00e9lyi","year":"2005"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0091625","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T07:12:06Z","timestamp":1562829126000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055589"}},"subtitle":[],"editor":[{"given":"Christopher","family":"Torrens","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055589","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}